ConductScience.org, home

Paper8094293

Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines.

Jensen PB and 4 others. Br J Cancer, 1993. Cited by 39 papers, by iCite.

Cite this record

ConductScience Library. Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines. Papers, record 8094293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8094293

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines.
PubMed
Journal
Br J Cancer
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
1.18
iCite
Revised in PubMed
2019-05-15
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jensen PBP B
2Christensen IJI J
3Sehested MM
4Hansen HHH H
5Vindeløv LL

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Carcinoma, Small CellMajor topic
EtoposideMajor topic
Lung NeoplasmsMajor topic
ATP Binding Cassette Transporter, Subfamily B, Member 1
DNA Topoisomerases, Type II
Daunorubicin
Drug Resistance
Drug Screening Assays, Antitumor
Humans
Membrane Glycoproteins
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12574988In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL).Br J Cancer1989https://conductscience.org/library/papers/2574988PubMed
22557299Reduced variation in the clonogenic assay obtained by standardization of the cell culture conditions prior to drug testing on human small cell lung cancer cell lines.Invest New Drugs1989https://conductscience.org/library/papers/2557299PubMed
31347865Management of small-cell cancer of the lung.Lancet1992https://conductscience.org/library/papers/1347865PubMed
41314232In vitro response of human small-cell lung-cancer cell lines to chemotherapeutic drugs; no correlation with clinical data.Int J Cancer1992https://conductscience.org/library/papers/1314232PubMed
51581902Relationship of VP-16 to the classical multidrug resistance phenotype.Cancer Res1992https://conductscience.org/library/papers/1581902PubMed
61350507Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening.Cancer Res1992https://conductscience.org/library/papers/1350507PubMed
71318157The 1991 Merck Frosst Award. Multidrug resistance in small cell lung cancer.Can J Physiol Pharmacol1992https://conductscience.org/library/papers/1318157PubMed
81360876Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivity.Cancer Chemother Pharmacol1992https://conductscience.org/library/papers/1360876PubMed
91967222Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line.Cancer Res1990https://conductscience.org/library/papers/1967222PubMed
102359137Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines.J Natl Cancer Inst1990https://conductscience.org/library/papers/2359137PubMed
111976450Characterization of an etoposide-resistant human small-cell lung cancer cell line.Cancer Chemother Pharmacol1990https://conductscience.org/library/papers/1976450PubMed
122174738Elevated expression of DNA topoisomerase II in camptothecin-resistant human tumor cell lines.Cancer Res1990https://conductscience.org/library/papers/2174738PubMed
132272241A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis.Cytometry1990https://conductscience.org/library/papers/2272241PubMed
141846554Chemosensitivity testing of small cell lung cancer using the MTT assay.Br J Cancer1991https://conductscience.org/library/papers/1846554PubMed
151963547Correlation of in vitro drug sensitivity testing of long-term small cell lung cancer cell lines with response and survival.Eur J Cancer1990https://conductscience.org/library/papers/1963547PubMed
161672252Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpression.Br J Cancer1991https://conductscience.org/library/papers/1672252PubMed
172023272MDR1 gene expression and treatment outcome in acute myeloid leukemia.J Natl Cancer Inst1991https://conductscience.org/library/papers/2023272PubMed
181674875Multidrug resistance (mdr) genes in human cancer.Br J Cancer1991https://conductscience.org/library/papers/1674875PubMed
191675932Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II.Cancer Res1991https://conductscience.org/library/papers/1675932PubMed
201874739Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data.J Biol Chem1991https://conductscience.org/library/papers/1874739PubMed

See all 45 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
31638975Investigation of anti-cancer and migrastatic properties of novel curcumin derivatives on breast and ovarian cancer cell lines.BMC Complement Altern Med2019https://conductscience.org/library/papers/31638975PubMed
28178691P-glycoprotein attenuates DNA repair activity in multidrug-resistant cells by acting through the Cbp-Csk-Src cascade.Oncotarget2017https://conductscience.org/library/papers/28178691PubMed
24758331Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance.Chem Rev2014https://conductscience.org/library/papers/24758331PubMed
21144000Target enzyme mutations are the molecular basis for resistance towards pharmacological inhibition of nicotinamide phosphoribosyltransferase.BMC Cancer2010https://conductscience.org/library/papers/21144000PubMed
17047657TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis.Br J Cancer2006https://conductscience.org/library/papers/17047657PubMed
9062409
In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin.
Br J Cancer1997https://conductscience.org/library/papers/9062409PubMed
7765327Human cell lines as models for multidrug resistance in solid tumours.Cytotechnology1993https://conductscience.org/library/papers/7765327PubMed
7669558An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein.Br J Cancer1995https://conductscience.org/library/papers/7669558PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
TOP2A7153PubTator's text mininghttps://conductscience.org/library/genes/7153NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8094293

GET https://conductscience.org/api/papers/v1/8094293/references?page=2